| Literature DB >> 28463419 |
Christine Lin1,2, Salman R Khetani2.
Abstract
Drug clearance rates from the body can determine drug exposure that can affect efficacy or toxicity. Thus, accurate prediction of drug clearance during preclinical development can help guide dose selection in humans, but animal testing is not always predictive of human outcomes. Because hepatic drug metabolism is a rate-limiting step in the overall clearance of many drugs, primary human hepatocytes (PHHs) in suspension cultures or monolayers are used for drug clearance predictions. Yet, the precipitous decline in drug metabolism capacity can lead to significant underestimation of clearance rates, particularly for low turnover compounds that have desirable one-pill-a-day dosing regimens. In contrast, micropatterned co-cultures (MPCCs) of PHHs and fibroblasts display phenotypic stability for several weeks and can help mitigate the limitations of conventional cultures. Here, we describe protocols to create and use MPCCs for drug clearance predictions, and for modeling clinically-relevant drug-drug interactions that can affect drug clearance. © 2017 by John Wiley & Sons, Inc.Entities:
Keywords: 3T3-J2 fibroblasts; cytochrome P450; drug metabolism; low turnover drugs; primary human hepatocytes
Mesh:
Substances:
Year: 2017 PMID: 28463419 PMCID: PMC5495000 DOI: 10.1002/cptx.23
Source DB: PubMed Journal: Curr Protoc Toxicol ISSN: 1934-9254